Oncogenic signatures mapped in TCGA aid in development of personalized therapy
Sunday, September 29, 2013 - 11:30
in Biology & Nature
Clinical trial design for new cancer therapies has historically been focused on the tissue of origin of a tumor, but a paper published in Nature Genetics supports a new approach: one based on the genomic signature of a tumor rather than the tissue of origin in the body.